Cefalex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cefalex

Quick Facts

Property Description
Active ingredient Cephalexin (INN)
Form Capsules, Tablets, Oral Suspension (liquid)
Pharmacological class First-Generation Cephalosporin Antibiotic
Common purpose Clearing bacterial infections
Origin Semisynthetic Derivative

What Type of Medicine is Cefalex (Cephalexin)?

Cefalex is the trade name for a prescribed medicinal product containing the active compound Cephalexin, which functions as a potent antimicrobial agent used to treat bacterial infections. Cefalex is formally classified as a semisynthetic beta-lactam antibiotic and belongs to the first-generation cephalosporin family of drugs. This compound is clinically recognized for its specific chemical structure, which provides documented effectiveness against a broad range of susceptible bacteria, particularly many common Gram-positive pathogens.

The core substance, Cephalexin, is a single-ingredient product recognized internationally by its nonproprietary name. Its origin is classified as a semisynthetic derivative, meaning it is chemically altered from a natural fungal foundation to optimize its stability and antibacterial performance. Cefalex is made available in several essential dosage forms for oral use, including solid capsules or tablets, as well as a liquid oral suspension reconstituted from powder, which offers flexible administration across patient groups.


What is the General Purpose of This Antibiotic?

The general purpose of Cefalex is to rapidly eliminate the source of bacterial infections within the body, achieving a powerful bactericidal effect by actively killing the pathogenic organisms. This action is rooted in the drug's fundamental mechanism: it disrupts the critical process of bacterial cell-wall synthesis.

Cefalex's core benefit is its ability to decisively clear bacterial populations by causing structural failure in the cell walls of susceptible microbes. By compromising this essential protective layer, the antibiotic facilitates the death of the bacteria, thereby helping to resolve the infectious process and supporting the body's recovery from illness. This makes it a standard treatment for situations such as common uncomplicated skin infections.

Regulatory References

  1. Cephalexin: MedlinePlus Drug Information

What side effects are possible with Cefalex?

Possible side effects and safety information

The safety profile of Cefalex (Cephalexin) is formally documented in regulatory texts, which classify possible adverse reactions based on body systems affected and their reported frequency. The most common side effects are typically related to the Gastrointestinal System, primarily diarrhoea and nausea. Other reactions classified as uncommon include skin rash and urticaria.

System-Organ-Class Safety Groups

Adverse effects are also categorized by the organ system involved. Reactions affecting the Blood and Lymphatic System (e.g., Eosinophilia) and Hepatobiliary Disorders (e.g., transient increases in liver enzymes) have been documented. Rare effects, such as Dizziness and Headache, are listed under Nervous System Disorders, while Reversible Interstitial Nephritis is a rare reaction affecting the Renal and Urinary System.

Serious Adverse Reactions and Safety Constraints

The official labeling highlights rare, but clinically serious, adverse reactions. These include severe allergic responses, such as Anaphylaxis, and the risk of Clostridioides difficile-Associated Diarrhea (CDAD), which may occur even after treatment is concluded. Severe skin reactions, including Stevens-Johnson syndrome, are also documented safety concerns. For certain patient populations, the risk profile is noted: caution is advised for individuals with renal impairment, where failure to adjust the dosage is associated with an increased risk of neurological events, including seizures. Prolonged use is officially associated with the potential for superinfection (overgrowth of non-susceptible organisms) and, in some cases, Prolonged Prothrombin Time.

Overdose and Emergency Response

Cefalex Overdose and When to Seek Help

Documented Clinical Manifestations

Official regulatory information states that an overdose of Cefalex (Cephalexin) may present with several acute systemic manifestations. These commonly include gastrointestinal distress such as nausea, vomiting, epigastric distress, and diarrhea. A specific urinary finding, haematuria (blood in the urine), has also been documented, particularly in pediatric cases involving high-dose ingestion.

Serious Outcomes and Risk Factors

The potential for seizures is a serious outcome documented for cephalosporins, emphasized in the context of Cefalex overdose, particularly when the drug accumulates. This risk is officially noted as being greater in patients with impaired renal function where the compound is not efficiently excreted. If seizures occur, regulatory information advises the product should be discontinued.

Mandatory Emergency Actions

Due to the absence of a known specific antidote, treatment for overdose must be solely symptomatic and supportive. In the event of any suspected overdose, regulatory guidance requires that immediate medical attention be sought. Emergency services must be contacted immediately if a patient collapses, experiences a seizure, or has difficulty breathing. Procedures such as hemodialysis or forced diuresis are officially listed as not being established as beneficial for drug removal.

Therapeutic Uses of Cefalex

What Cefalex Treats: Main Uses and Benefits

Cefalex is an antibiotic primarily utilized for the management of conditions involving bacterial infections that manifest with various acute symptoms across several body systems. It plays a role in addressing the source of the infection, which contributes to easing the overall symptom load and supports general well-being during symptomatic phases.

The medication is commonly used across conditions presenting with acute episodes of susceptible bacterial infections, including those affecting the skin and soft tissues (like cellulitis and impetigo), the upper respiratory tract (such as pharyngitis and tonsillitis), and the genitourinary tract (like uncomplicated cystitis). Cefalex is also applied in scenarios where additional management of discomfort is required in a preventive capacity, applied in addressing the risk of infection after certain medical procedures.

“Cefalex helps address symptom clusters that may become intense or disruptive, supporting the patient during difficult episodes by easing distress.”

Symptom Domain Key Benefit
Inflammatory Symptoms Helps ease localized pain, swelling, and redness in conditions involving inflammatory or irritative processes.
Urinary Distress Plays a role in managing symptoms of painful urination (dysuria) in conditions presenting with systemic or localized discomfort.
Systemic Discomfort Assists with maintaining functional stability during episodes of conditions marked by increased physiological stress.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Cefalex (Cephalexin)?

Contraindicated Populations

Cefalex is strictly contraindicated in any patient with a known hypersensitivity or severe allergic reaction to cephalexin or to any other member of the cephalosporin class of antibiotics. Due to the risk of cross-reactivity, caution is required if there is a history of allergy to penicillin. Some formulations are contraindicated in patients with rare hereditary issues like fructose intolerance, due to excipients.

Age-Group Eligibility

Eligibility for Cefalex is generally established for adults and pediatric patients over one year of age. Use in children under one year is conditional and requires explicit professional determination. For older adults, use is established, but care must be taken to evaluate kidney function.

Conditional Use and Restrictions

Conditional use is mandatory for individuals with markedly impaired renal function, as the drug is primarily cleared by the kidneys, and high concentrations may increase the risk of neurological issues. Caution is also advised for patients with a history of colitis or severe gastrointestinal disease. During pregnancy, Cefalex should be used only if clearly needed. It is excreted in human milk, meaning caution must be exercised if administered to a nursing mother.

What should I know about interactions with other medicines?

The official regulatory profile for Cefalex (Cephalexin) details specific interactions centered on its primary renal elimination pathway and risks of additive systemic effects. Co-administration with Probenecid formally inhibits the renal tubular secretion of Cephalexin, leading to documented increased and prolonged serum concentrations of the antibiotic. Conversely, Cephalexin itself is documented to alter the clearance of Metformin, resulting in an increase of Metformin's plasma peak concentration (Cmax) by an average of 34% and total systemic exposure (AUC) by 24%.

Pharmacodynamic cautions are established for combinations that carry an additive risk. Concomitant use with other nephrotoxic medicinal products, such as Aminoglycoside antibiotics or potent diuretics, may formally increase the risk of nephrotoxicity. Furthermore, the use of cephalosporins is associated with a risk of prolonged prothrombin time in individuals receiving anticoagulant therapy.

A specific timing restriction applies to mineral supplements containing iron or zinc, which interfere with absorption; these products must be administered at least 3 hours after the Cefalexin dose to prevent reduced absorption. While food may delay the absorption rate, the total amount absorbed remains unchanged, allowing Cefalexin to be taken without regard to meals.

Mechanism of Action

Targeting the Bacterial Cell Wall

Cefalex exerts its primary mode of action by selectively disrupting the construction of the bacterial cell wall. It functions as a beta-lactam agent that acts as an irreversible inhibitor of key bacterial enzymes known as penicillin-binding proteins (PBPs). These enzymes are crucial for the final stage of cell wall assembly, known as transpeptidation, which cross-links the peptidoglycan strands necessary for structural rigidity.


Mechanistic Cascade and Cell Lysis

The inhibition of peptidoglycan cross-linking prevents the bacterial cell wall from achieving structural integrity. This failure results in a structurally deficient cell wall that is unable to maintain the osmotic gradient. The resulting osmotic instability leads to the rapid swelling and rupture (lysis) of the bacterial cell. This mechanism is characterized by high selective toxicity for bacterial structures, resulting in a bactericidal (cell-killing) consequence.

Dosage and Administration Information

How Cefalex is Used: Official Administration Guidelines

The proper administration of Cefalex (cephalexin) is structured by specific instructions documented in prescribing information. The medicine is approved exclusively for oral administration, utilizing approved formats such as tablets, capsules, and a reconstituted liquid suspension.

Standard Dosage and Frequency

For adults, the usual administration pattern is a divided daily dose, typically prescribed as 250 mg every 6 hours or 500 mg every 12 hours. In cases of severe infection, the total daily quantity may be increased, though the maximum recommended daily dose is generally limited to 4 grams (4,000 mg), taken in two to four equal portions. The duration of use typically ranges from 7 to 14 days, with a minimum course of 10 days required for infections caused by beta-hemolytic streptococci.

Administration Conditions and Adjustments

Cefalex is acid stable and may be ingested without regard to meals. However, solid dosage forms must be taken with a full glass of water. If the liquid oral suspension is used, it must be shaken well prior to each administration. The official usage protocol mandates a required dose adjustment for patients with impaired kidney function; modifications are specifically detailed based on the patient's creatinine clearance to ensure proper systemic levels.


Official Use Protocol Structure

The official instructions establish a standardized oral delivery protocol, defining the necessary dose range and twice or four times daily frequency. These guidelines mandate specific procedural steps that must be followed for proper administration. The protocol is further modified by a required dose adjustment based on the patient's renal function and a duration constraint tied to the type of pathogen being addressed.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Cefalex

Evidence for Skin and Soft Tissue Infections

Research examining Cefalex for common skin and soft tissue infections, such as cellulitis and impetigo, includes short-term randomized controlled trials (RCTs) and systematic reviews. These studies were conducted to explore patterns related to the assessment of the status of physical signs of infection, such as swelling, redness, and purulent discharge, in both adult and pediatric patients. Researchers also monitored for the presence of the specific bacteria and tracked whether study participants required a change to a different antibiotic treatment.

Studies exploring short-term changes reported measurements of the evolution of the signs of infection observed during the typical 7 to 14-day treatment period. Some comparative trials demonstrated different patterns when measured against other agents studied for these conditions. However, there is limited information available from large, recent RCTs directly comparing the agent against all of the newer antibiotic agents currently in use. Furthermore, evidence is limited regarding its role in more complex or deep-seated skin infections.


Evidence for Upper Respiratory Tract Infections

Evidence for Genitourinary Tract Infections

The clinical research base for Cefalex has explored upper respiratory tract infections, including pharyngitis and tonsillitis, in previous RCTs and systematic reviews. These studies focused on episodes where symptoms become more noticeable, examining key outcomes such as the assessment of symptom change (like fever and sore throat) and measurements of the presence of the causative bacteria from the throat. Research describes that the agent was studied for these conditions in research contexts involving fluctuating or unstable symptoms.

Research for uncomplicated genitourinary tract infections, such as cystitis, includes both RCTs focused on dosing, as well as retrospective cohort studies. These studies primarily examined clinical status (assessment of urinary symptoms) and microbiological status (the presence of the bacteria in the urine), with follow-up periods extending up to 30 days to check for recurrence. While observational data exists, there is a lack of large-scale RCTs definitively establishing the optimal dosing frequency for all genitourinary infections.


Research Gaps and What Remains Uncertain

Overall, the available evidence is limited regarding long-term effects, as clinical trials typically focus on short-term outcomes observed during and immediately following the treatment course. Comparative evidence is lacking in certain indications, meaning large, modern RCTs are needed to compare the agent against all currently available competing treatments. Data are also still emerging for its role in settings facing high levels of antibiotic resistance.

Key Studies & References

  1. Twice daily cephalexin for uncomplicated urinary tract infection in women (Retrospective cohort study summary)
  2. Two Times Versus Four Times Daily Cephalexin Dosing for the Treatment of Uncomplicated Urinary Tract Infections in Females (Study Abstract)

Frequently Asked Questions (FAQ)

Common questions about Cefalex (FAQ)

Q: Is Cefalex a penicillin?

A: Cefalex (cephalexin) is officially classified as a first-generation cephalosporin antibiotic. While cephalosporins and penicillins both belong to the beta-lactam class, they possess different chemical structures. Regulatory documents note that caution is required if there is a history of allergy to penicillin due to the risk of cross-reactivity.

Q: What is the difference between Cefalex and amoxicillin?

A: Cefalex is a member of the first-generation cephalosporin family of drugs. Amoxicillin, by contrast, is categorized as a penicillin antibiotic. Both are used to treat bacterial infections, but their classification reflects differences in their chemical makeup and the spectrum of bacteria they are effective against.

Q: Can Cefalex cause a yeast infection?

A: Official documentation notes the potential for a superinfection from the overgrowth of non-susceptible organisms. Additionally, certain regulatory-sourced profiles specifically include 'vaginitis' or 'yeast infection' among the adverse reactions reported during use.

Q: Does Cefalex interact with birth control pills?

A: Some official drug resources note that Cefalex may potentially decrease the effectiveness of hormonal contraceptives, such as birth control pills. Due to this potential interaction, it is important to review all current medications with a healthcare provider.

Q: How long does Cefalex stay in your system after stopping it?

A: Official pharmacologic information indicates that Cefalex is rapidly absorbed into the body. Over 90% of the active drug is generally excreted unchanged in the urine within 8 hours of administration.

Q: Can Cefalex be taken with antacids?

A: Regulatory documents advise separating the dose of Cefalex from mineral supplements containing iron or zinc. While official documents caution against specific supplements, there is generally no explicit warning regarding common antacids.

Q: Does Cefalex treat viral infections like the common cold?

A: No, official regulatory guidance explicitly states that Cefalex is an antibacterial medicine and is not effective against viral infections. This means it is not indicated for treating conditions like the common cold or influenza.

Q: How quickly should Cefalex start working?

A: Official patient counseling materials note that individuals often begin to feel better early in the course of therapy. However, official documents do not provide a standardized timeline for when specific symptoms should begin to resolve.

Q: Is it normal to feel tired while taking Cefalex?

A: Fatigue or tiredness is included among the possible side effects reported during the use of cephalexin, according to some regulatory-based lists of adverse effects. Dizziness and Headache are also listed under Nervous System Disorders.

Q: Is Cefalex safe to take during pregnancy?

A: Cefalex is classified as Pregnancy Category B, meaning animal studies have generally not shown a risk. However, the official regulatory texts state that the medication is generally used during pregnancy only if clearly needed.

Q: What happens if I miss a dose of Cefalex?

A: Official counseling materials emphasize the importance of taking the medication exactly as directed and state that skipping doses may decrease its effectiveness. Regulatory sources do not provide specific 'catch-up' instructions for a single missed dose.

Q: Can I drink alcohol while taking Cefalex?

A: The official product label does not list a direct interaction between Cefalex and alcohol. Nonetheless, some official sources note that combining them may potentially increase the severity of certain documented gastrointestinal or nervous system side effects.

Q: Do I need to take Cefalex with food?

A: Cefalex is acid stable, and official prescribing information states that the medicine may be taken without regard to meals. While food may delay the rate at which the medicine is absorbed, the total amount that enters the body is not significantly affected.

Q: Is Cefalex the same as Keflex?

A: Keflex was the original brand name for the product containing the active ingredient cephalexin. Cefalex is a trade name for a product containing the same active ingredient, cephalexin, which is the generic name.

Q: Does Cefalex interact with common pain relievers like ibuprofen?

A: Official interaction lists do not typically name common non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen as a direct major interaction. However, regulatory warnings exist for concomitant use with other nephrotoxic medicinal products, which may formally increase the risk of kidney toxicity.

Q: Can Cefalex be used to prevent infections?

A: Official documentation states that Cefalex is formally indicated to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. General prophylactic use (preventing infection) is not listed as a primary indication.

Q: Is there a maximum time someone can take Cefalex?

A: The official document does not specify a maximum chronic use period. However, regulatory warnings state that prolonged use is officially associated with the potential for superinfection from the overgrowth of non-susceptible organisms.

Q: What research is available on the safety of Cefalex in children?

A: Official safety data lists adverse reactions observed in pediatric patients and notes the recommended dosage for children. Studies examining efficacy in children for conditions like skin and soft tissue infections are also noted in the official evidence summary.

Q: Does Cefalex treat sinus infections?

A: Official indications list Cefalex for respiratory tract infections, which may encompass sinus infections. The product information specifically names conditions such as tonsillitis and pharyngitis as indications.

Q: Is it possible to be allergic to Cefalex even if I'm not allergic to penicillin?

A: Yes, Cefalex is strictly contraindicated in any patient with a known hypersensitivity or severe allergic reaction to cephalexin itself or to any other member of the cephalosporin class of antibiotics.

Q: What are the signs of a severe allergic reaction to Cefalex?

A: The official labeling highlights rare but severe allergic responses, such as Anaphylaxis. Signs can include hives, trouble breathing, or swelling of the face, lips, tongue, or throat.

Q: Can Cefalex be used for dental infections?

A: Some authoritative international drug listings include dental infections as a recognized indication for Cefalex (cephalexin), based on its effectiveness against the types of bacteria commonly found in those infections.

Q: Does Cefalex affect blood sugar levels?

A: While Cefalex is not a diabetes medicine, official documents describe an interaction where the drug increases the systemic exposure of Metformin (a drug used for diabetes). The effect on blood sugar levels for individuals not taking Metformin is not explicitly stated.

Q: Does Cefalex affect the results of any laboratory tests?

A: Yes, official labeling notes that Cefalex can cause a false positive reaction for glucose in the urine when tested with certain solutions (like Benedict’s or Fehling’s). It can also cause a positive direct Coombs test.

Q: Can Cefalex interact with supplements or herbal products?

A: Official labeling specifically notes a timing restriction for mineral supplements containing iron or zinc. These products must be administered at least 3 hours after the Cefalex dose to prevent reduced absorption of the antibiotic.

Q: Why do some people experience drowsiness with Cefalex?

A: Official documentation lists certain central nervous system (CNS) effects, such as Dizziness and Headache, under Nervous System Disorders. These effects may be related to general feelings of grogginess or difficulty concentrating reported by some users.

Q: Is it safe to stop taking Cefalex early if I feel better?

A: Official patient counseling materials emphasize the importance of taking the full course exactly as directed. Stopping the medication too soon may result in a return of the infection.

Q: Can Cefalex be crushed or chewed?

A: Official instructions specify that solid dosage forms must be swallowed with a full glass of water, and the liquid suspension must be shaken. The regulatory product information does not contain instructions permitting the solid forms to be crushed or chewed.

Q: What should I avoid eating or drinking while on Cefalex?

A: Official documents specify that concurrent use with mineral supplements containing iron or zinc should be avoided by separating the doses by at least three hours. There is generally no broad food avoidance required, as the medicine can be taken without regard to meals.

Q: Does Cefalex affect kidney function?

A: Official documentation notes that Cefalex is primarily cleared by the kidneys, which is why a dose adjustment is required for patients with pre-existing kidney impairment. Reversible Interstitial Nephritis (a rare kidney reaction) is also listed as an adverse reaction.

Q: Is Cefalex safe for older adults?

A: Official documentation states that use of Cefalex in older adults is established. However, care is required to regularly evaluate kidney function in this population due to the drug's primary elimination pathway.

Q: How is Cefalex different from other cephalosporins?

A: Cefalex is officially classified as a first-generation cephalosporin. The cephalosporin family is divided into generations based on their chemical structure and the spectrum of bacteria they are effective against.

Q: What studies exist on Cefalex resistance?

A: Official regulatory texts contain guidance that Cefalex should be prescribed based on culture and susceptibility tests to confirm the bacteria is not resistant. The official document also warns that the use of antibiotics is associated with the development of drug-resistant bacteria.

Q: Are there special considerations for people with liver conditions taking Cefalex?

A: Official documentation lists Hepatobiliary Disorders (e.g., transient increases in liver enzymes) as documented adverse reactions. These effects may necessitate monitoring in individuals with pre-existing liver conditions.

How should Cefalex be stored and disposed of?

Storage and Disposal of Cephalexin (Cefalex)

The officially documented storage requirements for Cefalex vary by form. Capsules, tablets, and the dry powder must be stored at controlled room temperature (between 20 C and 25 C) and should be protected from moisture. All forms must be kept in the original container and out of the sight and reach of children.

The reconstituted liquid suspension requires storage in a refrigerator (2 C to 8 C) and must not be frozen. The liquid suspension has a limited shelf-life and must be discarded after 14 days of refrigeration.

Disposal of expired or unused Cefalex should primarily be handled through an authorized drug take-back program. If this is unavailable, the product must be mixed with an undesirable substance, sealed in a container, and placed in the household trash; the medicine is not on the list for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cefalex found in:

A-Z Index: